The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia
- 1 February 2003
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 160 (2) , 356-362
- https://doi.org/10.1176/appi.ajp.160.2.356
Abstract
OBJECTIVE: The authors’ goal was to consider ethical approaches to placebo-controlled clinical trials in the light of the evolving Declaration of Helsinki, with special attention to applications to...Keywords
This publication has 40 references indexed in Scilit:
- Enhancing Informed Consent for Research and TreatmentNeuropsychopharmacology, 2001
- Placebos on trialAnnals of Neurology, 2001
- Placebo‐controlled clinical trials in multiple sclerosis: Ethical considerationsAnnals of Neurology, 2001
- Decisional Capacity for Informed Consent in Schizophrenia ResearchArchives of General Psychiatry, 2000
- The use of placebo control groups in the assessment of psychiatric drugs: an historical contextBiological Psychiatry, 2000
- The long-term effects of placebo in patients with chronic schizophreniaBiological Psychiatry, 1999
- When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?Controlled Clinical Trials, 1997
- The Rationale and Ethics of Medication-Free Research in SchizophreniaArchives of General Psychiatry, 1997
- Neuroleptic Withdrawal in Schizophrenic PatientsArchives of General Psychiatry, 1995
- The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments.Law and Human Behavior, 1995